All Articles

As dozens of trusts weigh closure against staffing collapse, the NHS is being forced into a choice it has spent decades avoiding: proximity or survival.

As Advice and Guidance becomes contractually mandatory across general practice, the gap between its stated purpose and its lived effect is exposing how liability, not capacity, has become the NHS's quietest crisis.

Eleven cases in Barry since December have forced a five-day vaccination drive at a district hospital, and exposed how little the UK's immunisation architecture has adapted to a disease it has chosen to manage only after the fact.

HMRC's £78.2m Atos deal exposes a widening gap between how government departments spread technology risk and how the health service concentrates it.

Allergy Therapeutics' turnaround, and the case it makes for backing homegrown immunotherapy through a difficult financing climate.

The NHS events calendar is crowded, but the latest picture suggests that attention is concentrating around a relatively small number of meetings.

A Warrington screening scheme reveals the gap between NHS prevention rhetoric and the everyday mechanics of access.

The former finance director's promotion from interim to substantive leadership closes a six-month transition period as the ICB prepares to implement a new operating model under the 10 Year Health Plan.

The health secretary's blunt language on hospital discharge captures a decade-old failure, but fixing it demands more than a change of tone at the top of the department.

A five-year vision built on ambient voice and a single data platform sits alongside a more modest, and more telling, admission: tens of millions of pounds are needed simply to stop the network falling over.

A regional accelerator indicates that the more challenging obstacle for innovators is not the development of high-quality technology, but rather the process of understanding how the NHS purchases it. This is in response to the influx of capital into general practice software.

The elimination of hepatitis C would mark one of the NHS's quietest redemptions, but the funding and structures behind it are more fragile than the announcement suggests.

New data on GP earnings lands amid a funding dispute that exposes how far the structure of general practice has drifted from the workforce now delivering it.

Eliminating hepatitis C is possible, and its history reveals more about institutional memory than it does about medicine.

A new survey of American health system leaders reveals something much bigger than the rise of another successful software company. Epic is beginning to determine not simply how hospitals run, but which other technology companies are allowed to play. For NHS executive teams and the thousands of vendors hoping to sell into British healthcare, the implications are enormous.

A record half-year for AI investment says more about London's financial gravity than about what the NHS will actually receive.

Demis Hassabis stepping back from DeepMind revives an unresolved question about what Big Tech owes the health system it once used to prove itself.

Ireland has just standardised something the NHS has never managed to agree upon nationally, and the contrast says more about the state of maternity safety in England than any single policy failure could.

The Department of Health tests candidates for high-paying executive positions using a demanding Public Accounts Committee simulation.

Great British Energy has found almost £9 million to build a British factory for renewable heat. Hospitals, meanwhile, are still burning gas to keep their wards warm, and the money to change that keeps arriving too slowly and too late.